Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
Clinical trial NCT01195779 · TERMINATED
Trial details
- NCT number
- NCT01195779
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-30
- Primary completion
- 2011-03-22
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.